内分泌干扰物通过干扰内分泌系统导致多种疾病,如生殖疾病、肥胖症甚至癌症。然而,面对环境中大量潜在的内分泌干扰物,传统的体外、体内评估方法由于成本高、耗时长等问题,难以实现内分泌干扰物的高通量筛查。计算毒理学逐渐发展成为被...内分泌干扰物通过干扰内分泌系统导致多种疾病,如生殖疾病、肥胖症甚至癌症。然而,面对环境中大量潜在的内分泌干扰物,传统的体外、体内评估方法由于成本高、耗时长等问题,难以实现内分泌干扰物的高通量筛查。计算毒理学逐渐发展成为被美国环保局(Environmental Protection Agency,EPA)、经济合作与发展组织(Organization for Economic Co-operation and Development,OECD)等机构所推荐的内分泌干扰物筛选与预测方法。本文综述了计算毒理学在内分泌干扰物筛选上的进展,主要包括分子对接和分子动力学模拟的应用,并对有害结局路径(adverse outcome pathway,AOP)的方法进行介绍和展望。展开更多
环境内分泌干扰物(endocrine disrupting chemicals,EDCs)可模仿或拮抗天然激素与核受体结合,干扰核受体的同源或异源二聚,进而通过共调节因子的招募调控转录活性,最终引起内分泌干扰效应。目前研究主要针对EDCs与核受体的结合过程,忽...环境内分泌干扰物(endocrine disrupting chemicals,EDCs)可模仿或拮抗天然激素与核受体结合,干扰核受体的同源或异源二聚,进而通过共调节因子的招募调控转录活性,最终引起内分泌干扰效应。目前研究主要针对EDCs与核受体的结合过程,忽视了其对核受体二聚化过程的影响,而该过程的阻断可直接导致转录失活。EDCs对于不同核受体二聚化的影响不同,只有激动剂EDCs能够促进雄激素受体(androgen receptor,AR)的同源二聚化,而雌激素受体(estrogen receptor,ER)在与具有激动或拮抗活性的EDCs结合后都可诱导ER二聚体的形成,但二聚化类型不同。通过检索ToxCast和Tox21数据库发现多达227种EDCs可以诱导ER二聚化,相比于ERα-ERα同源二聚体(6.09%~7.38%的活性率),EDCs更易诱导ERα-ERβ异源二聚体(11.25%~12.22%的活性率)和ERβ-ERβ同源二聚体(10.02%~11.69%的活性率)。EDCs也能够差异性诱导其他核受体如维生素D受体(vitamin D receptor,VDR)与维甲酸X受体(retinoid X receptor,RXR)形成的异源二聚体,不同类型的二聚体对于研究EDCs转录活性的生理学相关性具有重要意义。基于经济合作与发展组织(Organization for Economic Co-operation and Development,OECD)报告的参考化学品研究发现,相比于配受体结合活性,二聚活性与转录活性之间有着更好的相关关系。本文从EDCs介导的核受体二聚化转录机制、二聚化与转录活性间的关系以及二聚化研究方法三方面,总结EDCs对核受体二聚化的影响,以期为深入理解EDCs的分子作用机制,推进化合物的内分泌干扰风险评估提供参考。展开更多
The CRISPR-Cas9 system,serving as a powerful genome-editing technology,has revolutionized the life sciences.However,it exhibits off-target activities that may present severe problems in clinical applications.Although ...The CRISPR-Cas9 system,serving as a powerful genome-editing technology,has revolutionized the life sciences.However,it exhibits off-target activities that may present severe problems in clinical applications.Although a great number of in silico models have been developed to predict CRISPR targeting efficiency and specificity,they are running into a bottleneck with the lack of a mechanistic understanding of the on-and off-target activities of Cas9.展开更多
文摘内分泌干扰物通过干扰内分泌系统导致多种疾病,如生殖疾病、肥胖症甚至癌症。然而,面对环境中大量潜在的内分泌干扰物,传统的体外、体内评估方法由于成本高、耗时长等问题,难以实现内分泌干扰物的高通量筛查。计算毒理学逐渐发展成为被美国环保局(Environmental Protection Agency,EPA)、经济合作与发展组织(Organization for Economic Co-operation and Development,OECD)等机构所推荐的内分泌干扰物筛选与预测方法。本文综述了计算毒理学在内分泌干扰物筛选上的进展,主要包括分子对接和分子动力学模拟的应用,并对有害结局路径(adverse outcome pathway,AOP)的方法进行介绍和展望。
文摘环境内分泌干扰物(endocrine disrupting chemicals,EDCs)可模仿或拮抗天然激素与核受体结合,干扰核受体的同源或异源二聚,进而通过共调节因子的招募调控转录活性,最终引起内分泌干扰效应。目前研究主要针对EDCs与核受体的结合过程,忽视了其对核受体二聚化过程的影响,而该过程的阻断可直接导致转录失活。EDCs对于不同核受体二聚化的影响不同,只有激动剂EDCs能够促进雄激素受体(androgen receptor,AR)的同源二聚化,而雌激素受体(estrogen receptor,ER)在与具有激动或拮抗活性的EDCs结合后都可诱导ER二聚体的形成,但二聚化类型不同。通过检索ToxCast和Tox21数据库发现多达227种EDCs可以诱导ER二聚化,相比于ERα-ERα同源二聚体(6.09%~7.38%的活性率),EDCs更易诱导ERα-ERβ异源二聚体(11.25%~12.22%的活性率)和ERβ-ERβ同源二聚体(10.02%~11.69%的活性率)。EDCs也能够差异性诱导其他核受体如维生素D受体(vitamin D receptor,VDR)与维甲酸X受体(retinoid X receptor,RXR)形成的异源二聚体,不同类型的二聚体对于研究EDCs转录活性的生理学相关性具有重要意义。基于经济合作与发展组织(Organization for Economic Co-operation and Development,OECD)报告的参考化学品研究发现,相比于配受体结合活性,二聚活性与转录活性之间有着更好的相关关系。本文从EDCs介导的核受体二聚化转录机制、二聚化与转录活性间的关系以及二聚化研究方法三方面,总结EDCs对核受体二聚化的影响,以期为深入理解EDCs的分子作用机制,推进化合物的内分泌干扰风险评估提供参考。
基金supported by the National Key Research and Development Program of China(2021YFF1201200,2021YFF1200900)the National Natural Science Foundation of China(31970638,61572361,62102286,and 62002265)+4 种基金Roche pRED Informatics Advanced Analytics Postdoctoral Fellowship Program(aligned with the Roche pRED Postdoctoral Fellowship Program RPF-500)Shanghai Natural Science Foundation Program(17ZR1449400)Shanghai Artificial Intelligence Technology Standard Project(19DZ2200900)Shanghai Shuguang Scholars ProjectWe Bank Scholars Project and Fundamental Research Funds for the Central Universities。
文摘The CRISPR-Cas9 system,serving as a powerful genome-editing technology,has revolutionized the life sciences.However,it exhibits off-target activities that may present severe problems in clinical applications.Although a great number of in silico models have been developed to predict CRISPR targeting efficiency and specificity,they are running into a bottleneck with the lack of a mechanistic understanding of the on-and off-target activities of Cas9.